Charles Schwab
RXST icon

Charles Schwab’s RxSight RXST Stock Holding History

Charles Schwab’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
312,782
+11,160
+4% +$67.4K ﹤0.01% 2882
2026
Q1 		$1.86M Buy
301,622
+10,608
+4% +$88.1K ﹤0.01% 2737
2025
Q4 		$3.03M Buy
291,014
+30,973
+12% +$311K ﹤0.01% 2631
2025
Q3 		$2.34M Sell
260,041
-32,276
-11% -$283K ﹤0.01% 2713
2025
Q2 		$3.8M Buy
292,317
+4,994
+2% +$75.1K ﹤0.01% 2447
2025
Q1 		$7.25M Sell
287,323
-3,431
-1% -$102K ﹤0.01% 2108
2024
Q4 		$10M Buy
290,754
+5,425
+2% +$245K ﹤0.01% 2013
2024
Q3 		$14.1M Buy
285,329
+62,507
+28% +$3.2M ﹤0.01% 1878
2024
Q2 		$13.4M Buy
222,822
+29,078
+15% +$1.66M ﹤0.01% 1892
2024
Q1 		$9.99M Buy
193,744
+3,407
+2% +$167K ﹤0.01% 1984
2023
Q4 		$7.67M Buy
190,337
+8,003
+4% +$235K ﹤0.01% 2129
2023
Q3 		$5.09M Buy
182,334
+111,403
+157% +$3.32M ﹤0.01% 2254
2023
Q2 		$2.04M Buy
70,931
+10,155
+17% +$226K ﹤0.01% 2545
2023
Q1 		$1.01M Buy
60,776
+7,464
+14% +$105K ﹤0.01% 2726
2022
Q4 		$675K Buy
53,312
+1,214
+2% +$14.8K ﹤0.01% 2909
2022
Q3 		$626K Buy
52,098
+3,522
+7% +$48.4K ﹤0.01% 2938
2022
Q2 		$684K Buy
48,576
+6,106
+14% +$80.5K ﹤0.01% 2936
2022
Q1 		$526K Buy
42,470
+19,835
+88% +$238K ﹤0.01% 3087
2021
Q4 		$255K Buy
22,635
+2,457
+12% +$29.5K ﹤0.01% 3315
2021
Q3 		$256K Buy
+20,178
New +$278K ﹤0.01% 3295

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Charles Schwab's RXST Position: Q2 2026 in Review

Charles Schwab increased its RxSight (RXST) stake by 3.7% in Q2 2026, buying an estimated $67.4K and bringing the position to 312,782 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

Charles Schwab first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $14.1M in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Charles Schwab held 312,782 shares of RxSight worth $1.51M as of Q2 2026.
  • Charles Schwab bought 11,160 RxSight shares in Q2 2026, an estimated $67.4K.
  • RxSight made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2882 holding.
  • Charles Schwab first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Charles Schwab's RxSight position peaked at $14.1M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.